Update on cirrhotic cardiomyopathy: from etiopathogenesis to treatment

Area of Science:

• Cardiology
• Hepatology
• Internal Medicine

Background:

• Cirrhotic cardiomyopathy is a cardiac dysfunction linked to advanced liver disease, often carrying a poor prognosis.
• It stems from complex pathophysiological processes including portal hypertension, hyperdynamic circulation, and neurohumoral axis over-activation.
• Hepatocellular insufficiency and altered vasoactive mediators contribute significantly to the condition's development.

Purpose of the Study:

• To highlight the key aspects of cirrhotic cardiomyopathy.
• To draw attention to this underdiagnosed condition in patients with chronic liver disease.
• To emphasize the importance of identifying cirrhotic cardiomyopathy for improved patient outcomes.

Main Methods:

• This article provides a review of the pathophysiology and diagnostic challenges of cirrhotic cardiomyopathy.
• It discusses the multimodal approach required for diagnosis.
• It examines current therapeutic considerations and their impact on prognosis.

Main Results:

• Cirrhotic cardiomyopathy is characterized by cardiac dysfunction in advanced liver disease.
• Portal hypertension is a primary driver, leading to hyperdynamic circulation.
• Diagnosis is challenging, often requiring stress testing, and no specific therapy exists.

Conclusions:

• Cirrhotic cardiomyopathy is a significant complication of advanced liver disease with a poor prognosis.
• Early identification and management, utilizing available heart failure therapies, are crucial for ameliorating patient outcomes.
• Further research and clinical attention are needed to address this complex condition.